SS-Adora2bem2Mcwi |
stroke volume |
angiotensin II (200 ng/kg/min) (for 14 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
blood flow trait |
male |
63 days-70 days |
7 |
0.19 |
ml |
0.01 |
0.03 |
transthoracic echocardiography |
0.0 |
0 |
|
105841 |
3023 |
SS-Adora2bem2Mcwi |
stroke volume |
angiotensin II (200 ng/kg/min) (for 28 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
blood flow trait |
male |
77 days-84 days |
7 |
0.2 |
ml |
0.02 |
0.04 |
transthoracic echocardiography |
0.0 |
0 |
|
105843 |
3023 |
SHRSP/A3NCrl |
stroke volume |
controlled sodium chloride content drinking water (1 %) (for 49 days) and controlled fat content diet (24.5 %) (for 49 days) then controlled GSK2181236A content diet (1 mg/kg/d) (for 42 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
cardiac output trait |
male |
134 days-141 days |
10 |
234000.0 |
ml |
14000.0 |
44271.89 |
transthoracic echocardiography |
0.0 |
0 |
3-5 cardiac cycles |
107031 |
3073 |
SS/JrHsdMcwi |
stroke volume |
angiotensin II (200 ng/kg/min) (for 14 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
blood flow trait |
male |
63 days-70 days |
5 |
0.2 |
ml |
0.03 |
0.06 |
transthoracic echocardiography |
0.0 |
0 |
|
105840 |
3023 |
SS/JrHsdMcwi |
stroke volume |
isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
blood flow trait |
male |
147 days
| 10 |
0.26 |
ml |
0.01 |
0.03 |
transthoracic echocardiography |
0.0 |
0 |
|
105804 |
3023 |
SS/JrHsdMcwi |
stroke volume |
isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
blood flow trait |
male |
49 days-56 days |
5 |
0.2 |
ml |
0.01 |
0.02 |
transthoracic echocardiography |
0.0 |
0 |
|
105838 |
3023 |
SHRSP/A3NCrl |
stroke volume |
control condition |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
cardiac output trait |
male |
134 days-141 days |
8 |
255000.0 |
ml |
9000.0 |
25455.84 |
transthoracic echocardiography |
0.0 |
0 |
3-5 cardiac cycles |
107028 |
3073 |
SHRSP/A3NCrl |
stroke volume |
controlled sodium chloride content drinking water (1 %) (for 49 days) and controlled fat content diet (24.5 %) (for 49 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
cardiac output trait |
male |
134 days-141 days |
11 |
229000.0 |
ml |
10000.0 |
33166.25 |
transthoracic echocardiography |
0.0 |
0 |
3-5 cardiac cycles |
107029 |
3073 |
SHRSP/A3NCrl |
stroke volume |
controlled sodium chloride content drinking water (1 %) (for 49 days) and controlled fat content diet (24.5 %) (for 49 days) then controlled GSK2181236A content diet (0.1 mg/kg/d) (for 42 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
cardiac output trait |
male |
134 days-141 days |
6 |
222000.0 |
ml |
19000.0 |
46540.31 |
transthoracic echocardiography |
0.0 |
0 |
3-5 cardiac cycles |
107030 |
3073 |
SHRSP/A3NCrl |
stroke volume |
controlled sodium chloride content drinking water (1 %) (for 49 days) and controlled fat content diet (24.5 %) (for 49 days) then controlled BAY60-4552 content diet (0.3 mg/kg/d) (for 42 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
cardiac output trait |
male |
134 days-141 days |
9 |
245000.0 |
ml |
14000.0 |
42000.0 |
transthoracic echocardiography |
0.0 |
0 |
3-5 cardiac cycles |
107032 |
3073 |
SHRSP/A3NCrl |
stroke volume |
controlled sodium chloride content drinking water (1 %) (for 49 days) and controlled fat content diet (24.5 %) (for 49 days) then controlled BAY60-4552 content diet (3 mg/kg/d) (for 42 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
cardiac output trait |
male |
134 days-141 days |
10 |
259000.0 |
ml |
13000.0 |
41109.61 |
transthoracic echocardiography |
0.0 |
0 |
3-5 cardiac cycles |
107033 |
3073 |
SS-Adora2bem2Mcwi |
stroke volume |
isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
blood flow trait |
male |
147 days
| 10 |
0.26 |
ml |
0.01 |
0.03 |
transthoracic echocardiography |
0.0 |
0 |
|
105805 |
3023 |
SS-Adora2bem2Mcwi |
stroke volume |
isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
blood flow trait |
male |
49 days-56 days |
7 |
0.21 |
ml |
0.01 |
0.03 |
transthoracic echocardiography |
0.0 |
0 |
|
105839 |
3023 |
SS/JrHsdMcwi |
stroke volume |
angiotensin II (200 ng/kg/min) (for 28 days) then isoflurane (1-2 %) |
Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. |
blood flow trait |
male |
77 days-84 days |
5 |
0.22 |
ml |
0.02 |
0.05 |
transthoracic echocardiography |
0.0 |
0 |
|
105842 |
3023 |